Jurong Town Corporation – Trademark Portfolio
Entity Type: 03
Jurong Town Corporation holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 8 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include BIOPOLIS, ONE-NORTH, MEDIAPOLIS, and FUSIONOPOLIS. The owner is based in Singapore.
The JTC Summit
8 Jurong Town Hall Road
Singapore 609434 , SG
Showing of trademarks Trademarks
Trademark Classifications
Jurong Town Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Jurong Town Corporation have?
Jurong Town Corporation has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 1 abandoned, 2 cancelled.
What trademark classes does Jurong Town Corporation file in?
Jurong Town Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Jurong Town Corporation's most well-known trademarks?
Jurong Town Corporation's registered trademark portfolio includes well-known marks such as BIOPOLIS, ONE-NORTH, MEDIAPOLIS, and FUSIONOPOLIS. These are among 5 currently registered trademarks in the portfolio.
What is Jurong Town Corporation's trademark registration success rate?
Jurong Town Corporation has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 1 application is pending review.